Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 225

1.

The role of vasopressin V1A receptors in cytotoxic brain edema formation following brain injury.

Kleindienst A, Dunbar JG, Glisson R, Marmarou A.

Acta Neurochir (Wien). 2013 Jan;155(1):151-64. doi: 10.1007/s00701-012-1558-z. Epub 2012 Nov 28.

PMID:
23188468
2.

Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial.

Naff N, Williams MA, Keyl PM, Tuhrim S, Bullock MR, Mayer SA, Coplin W, Narayan R, Haines S, Cruz-Flores S, Zuccarello M, Brock D, Awad I, Ziai WC, Marmarou A, Rhoney D, McBee N, Lane K, Hanley DF Jr.

Stroke. 2011 Nov;42(11):3009-16. doi: 10.1161/STROKEAHA.110.610949. Epub 2011 Aug 25.

3.

Impact of GOS misclassification on ordinal outcome analysis of traumatic brain injury clinical trials.

Lu J, Marmarou A, Lapane KL; IMPACT Investigators.

J Neurotrauma. 2012 Mar 20;29(5):719-26. doi: 10.1089/neu.2010.1746. Epub 2011 Sep 21.

4.

Brain energy depletion in a rodent model of diffuse traumatic brain injury is not prevented with administration of sodium lactate.

Prieto R, Tavazzi B, Taya K, Barrios L, Amorini AM, Di Pietro V, Pascual JM, Marmarou A, Marmarou CR.

Brain Res. 2011 Aug 2;1404:39-49. doi: 10.1016/j.brainres.2011.06.006. Epub 2011 Jun 12.

5.

Xenon-enhanced cerebral blood flow at 28% xenon provides uniquely safe access to quantitative, clinically useful cerebral blood flow information: a multicenter study.

Carlson AP, Brown AM, Zager E, Uchino K, Marks MP, Robertson C, Sinson GP, Marmarou A, Yonas H.

AJNR Am J Neuroradiol. 2011 Aug;32(7):1315-20. doi: 10.3174/ajnr.A2522. Epub 2011 Jun 23.

6.

Large between-center differences in outcome after moderate and severe traumatic brain injury in the international mission on prognosis and clinical trial design in traumatic brain injury (IMPACT) study.

Lingsma HF, Roozenbeek B, Li B, Lu J, Weir J, Butcher I, Marmarou A, Murray GD, Maas AI, Steyerberg EW.

Neurosurgery. 2011 Mar;68(3):601-7; discussion 607-8. doi: 10.1227/NEU.0b013e318209333b.

PMID:
21311293
7.

Comparison between 3 infusion methods to measure cerebrospinal fluid outflow conductance.

Sundström N, Andersson K, Marmarou A, Malm J, Eklund A.

J Neurosurg. 2010 Dec;113(6):1294-303. doi: 10.3171/2010.8.JNS10157. Epub 2010 Sep 10.

PMID:
20831359
8.

A method for reducing misclassification in the extended Glasgow Outcome Score.

Lu J, Marmarou A, Lapane K, Turf E, Wilson L; IMPACT Group; American Brain Injury Consortium Study Participation Centers.

J Neurotrauma. 2010 May;27(5):843-52. doi: 10.1089/neu.2010.1293.

9.

A simulation study evaluating approaches to the analysis of ordinal outcome data in randomized controlled trials in traumatic brain injury: results from the IMPACT Project.

McHugh GS, Butcher I, Steyerberg EW, Marmarou A, Lu J, Lingsma HF, Weir J, Maas AI, Murray GD.

Clin Trials. 2010 Feb;7(1):44-57. doi: 10.1177/1740774509356580.

PMID:
20156956
10.

IMPACT recommendations for improving the design and analysis of clinical trials in moderate to severe traumatic brain injury.

Maas AI, Steyerberg EW, Marmarou A, McHugh GS, Lingsma HF, Butcher I, Lu J, Weir J, Roozenbeek B, Murray GD.

Neurotherapeutics. 2010 Jan;7(1):127-34. doi: 10.1016/j.nurt.2009.10.020. Review.

11.

Baseline characteristics and statistical power in randomized controlled trials: selection, prognostic targeting, or covariate adjustment?

Roozenbeek B, Maas AI, Lingsma HF, Butcher I, Lu J, Marmarou A, McHugh GS, Weir J, Murray GD, Steyerberg EW; IMPACT Study Group.

Crit Care Med. 2009 Oct;37(10):2683-90.

PMID:
19885979
12.

The protein kinase C activator phorbol myristate acetate decreases brain edema by aquaporin 4 downregulation after middle cerebral artery occlusion in the rat.

Fazzina G, Amorini AM, Marmarou CR, Fukui S, Okuno K, Dunbar JG, Glisson R, Marmarou A, Kleindienst A.

J Neurotrauma. 2010 Feb;27(2):453-61. doi: 10.1089/neu.2008.0782.

13.

Effect of secondary insults upon aquaporin-4 water channels following experimental cortical contusion in rats.

Taya K, Marmarou CR, Okuno K, Prieto R, Marmarou A.

J Neurotrauma. 2010 Jan;27(1):229-39. doi: 10.1089/neu.2009.0933.

14.

The influence of enrollment criteria on recruitment and outcome distribution in traumatic brain injury studies: results from the impact study.

Roozenbeek B, Maas AI, Marmarou A, Butcher I, Lingsma HF, Lu J, McHugh GS, Murray GD, Steyerberg EW; IMPACT Study Group.

J Neurotrauma. 2009 Jul;26(7):1069-75. doi: 10.1089/neu.2008.0569.

15.

Frequency of sustained intracranial pressure elevation during treatment of severe intraventricular hemorrhage.

Ziai WC, Torbey MT, Naff NJ, Williams MA, Bullock R, Marmarou A, Tuhrim S, Schmutzhard E, Pfausler B, Hanley DF.

Cerebrovasc Dis. 2009;27(4):403-10. doi: 10.1159/000209241. Epub 2009 Mar 18.

16.

Outcome in 1,000 head injury hospital admissions: the Athens head trauma registry.

Stranjalis G, Bouras T, Korfias S, Andrianakis I, Pitaridis M, Tsamandouraki K, Alamanos Y, Sakas DE, Marmarou A.

J Trauma. 2008 Oct;65(4):789-93. doi: 10.1097/TA.0b013e3181469e26.

PMID:
18849792
17.

Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics.

Steyerberg EW, Mushkudiani N, Perel P, Butcher I, Lu J, McHugh GS, Murray GD, Marmarou A, Roberts I, Habbema JD, Maas AI.

PLoS Med. 2008 Aug 5;5(8):e165; discussion e165. doi: 10.1371/journal.pmed.0050165.

18.

Effects of Glasgow Outcome Scale misclassification on traumatic brain injury clinical trials.

Lu J, Murray GD, Steyerberg EW, Butcher I, McHugh GS, Lingsma H, Mushkudiani N, Choi S, Maas AI, Marmarou A.

J Neurotrauma. 2008 Jun;25(6):641-51. doi: 10.1089/neu.2007.0510.

19.

Phenomenology of prolonged febrile seizures: results of the FEBSTAT study.

Shinnar S, Hesdorffer DC, Nordli DR Jr, Pellock JM, O'Dell C, Lewis DV, Frank LM, Moshé SL, Epstein LG, Marmarou A, Bagiella E; FEBSTAT Study Team.

Neurology. 2008 Jul 15;71(3):170-6. doi: 10.1212/01.wnl.0000310774.01185.97. Epub 2008 Jun 4.

PMID:
18525033
20.

Assessment of mitochondrial impairment in traumatic brain injury using high-resolution proton magnetic resonance spectroscopy.

Signoretti S, Marmarou A, Aygok GA, Fatouros PP, Portella G, Bullock RM.

J Neurosurg. 2008 Jan;108(1):42-52. doi: 10.3171/JNS/2008/108/01/0042.

PMID:
18173309
21.

The modulation of aquaporin-4 by using PKC-activator (phorbol myristate acetate) and V1a receptor antagonist (SR49059) following middle cerebral artery occlusion/reperfusion in the rat.

Okuno K, Taya K, Marmarou CR, Ozisik P, Fazzina G, Kleindienst A, Gulsen S, Marmarou A.

Acta Neurochir Suppl. 2008;102:431-6.

PMID:
19388361
22.

Modulation of AQP4 expression by the selective V1a receptor antagonist, SR49059, decreases trauma-induced brain edema.

Taya K, Gulsen S, Okuno K, Prieto R, Marmarou CR, Marmarou A.

Acta Neurochir Suppl. 2008;102:425-9.

PMID:
19388360
23.

Assessment of mitochondrial impairment and cerebral blood flow in severe brain injured patients.

Aygok GA, Marmarou A, Fatouros P, Kettenmann B, Bullock RM.

Acta Neurochir Suppl. 2008;102:57-61.

PMID:
19388289
24.

Assessment of cerebrospinal fluid outflow resistance.

Eklund A, Smielewski P, Chambers I, Alperin N, Malm J, Czosnyka M, Marmarou A.

Med Biol Eng Comput. 2007 Aug;45(8):719-35. Epub 2007 Jul 17. Review.

PMID:
17634761
25.

A review of progress in understanding the pathophysiology and treatment of brain edema.

Marmarou A.

Neurosurg Focus. 2007 May 15;22(5):E1. Review.

PMID:
17613227
26.
27.

Multivariable prognostic analysis in traumatic brain injury: results from the IMPACT study.

Murray GD, Butcher I, McHugh GS, Lu J, Mushkudiani NA, Maas AI, Marmarou A, Steyerberg EW.

J Neurotrauma. 2007 Feb;24(2):329-37.

PMID:
17375997
28.

Prognostic value of admission laboratory parameters in traumatic brain injury: results from the IMPACT study.

Van Beek JG, Mushkudiani NA, Steyerberg EW, Butcher I, McHugh GS, Lu J, Marmarou A, Murray GD, Maas AI.

J Neurotrauma. 2007 Feb;24(2):315-28.

PMID:
17375996
29.

Prognostic value of computerized tomography scan characteristics in traumatic brain injury: results from the IMPACT study.

Maas AI, Steyerberg EW, Butcher I, Dammers R, Lu J, Marmarou A, Mushkudiani NA, McHugh GS, Murray GD.

J Neurotrauma. 2007 Feb;24(2):303-14.

PMID:
17375995
30.

Prognostic value of admission blood pressure in traumatic brain injury: results from the IMPACT study.

Butcher I, Maas AI, Lu J, Marmarou A, Murray GD, Mushkudiani NA, McHugh GS, Steyerberg EW.

J Neurotrauma. 2007 Feb;24(2):294-302.

PMID:
17375994
31.

Prognostic value of secondary insults in traumatic brain injury: results from the IMPACT study.

McHugh GS, Engel DC, Butcher I, Steyerberg EW, Lu J, Mushkudiani N, Hernández AV, Marmarou A, Maas AI, Murray GD.

J Neurotrauma. 2007 Feb;24(2):287-93.

PMID:
17375993
32.

Prognostic value of cause of injury in traumatic brain injury: results from the IMPACT study.

Butcher I, McHugh GS, Lu J, Steyerberg EW, Hernández AV, Mushkudiani N, Maas AI, Marmarou A, Murray GD.

J Neurotrauma. 2007 Feb;24(2):281-6.

PMID:
17375992
33.

Prognostic value of the Glasgow Coma Scale and pupil reactivity in traumatic brain injury assessed pre-hospital and on enrollment: an IMPACT analysis.

Marmarou A, Lu J, Butcher I, McHugh GS, Murray GD, Steyerberg EW, Mushkudiani NA, Choi S, Maas AI.

J Neurotrauma. 2007 Feb;24(2):270-80.

PMID:
17375991
34.

Prognostic value of demographic characteristics in traumatic brain injury: results from the IMPACT study.

Mushkudiani NA, Engel DC, Steyerberg EW, Butcher I, Lu J, Marmarou A, Slieker F, McHugh GS, Murray GD, Maas AI.

J Neurotrauma. 2007 Feb;24(2):259-69.

PMID:
17375990
35.

Statistical approaches to the univariate prognostic analysis of the IMPACT database on traumatic brain injury.

McHugh GS, Butcher I, Steyerberg EW, Lu J, Mushkudiani N, Marmarou A, Maas AI, Murray GD.

J Neurotrauma. 2007 Feb;24(2):251-8.

PMID:
17375989
36.

IMPACT database of traumatic brain injury: design and description.

Marmarou A, Lu J, Butcher I, McHugh GS, Mushkudiani NA, Murray GD, Steyerberg EW, Maas AI.

J Neurotrauma. 2007 Feb;24(2):239-50.

PMID:
17375988
37.

Prognosis and clinical trial design in traumatic brain injury: the IMPACT study.

Maas AI, Marmarou A, Murray GD, Teasdale SG, Steyerberg EW.

J Neurotrauma. 2007 Feb;24(2):232-8. Review.

PMID:
17375987
38.

Adjustment for strong predictors of outcome in traumatic brain injury trials: 25% reduction in sample size requirements in the IMPACT study.

Hernández AV, Steyerberg EW, Butcher I, Mushkudiani N, Taylor GS, Murray GD, Marmarou A, Choi SC, Lu J, Habbema JD, Maas AI.

J Neurotrauma. 2006 Sep;23(9):1295-303.

PMID:
16958582
39.

Predominance of cellular edema in traumatic brain swelling in patients with severe head injuries.

Marmarou A, Signoretti S, Fatouros PP, Portella G, Aygok GA, Bullock MR.

J Neurosurg. 2006 May;104(5):720-30.

PMID:
16703876
40.

Modulation of AQP4 expression by the protein kinase C activator, phorbol myristate acetate, decreases ischemia-induced brain edema.

Kleindienst A, Fazzina G, Amorini AM, Dunbar JG, Glisson R, Marmarou A.

Acta Neurochir Suppl. 2006;96:393-7.

PMID:
16671492
41.

Brain tissue water content in patients with idiopathic normal pressure hydrocephalus.

Aygok G, Marmarou A, Fatouros P, Young H.

Acta Neurochir Suppl. 2006;96:348-51.

PMID:
16671483
42.

Protective effect of the V1a receptor antagonist SR49059 on brain edema formation following middle cerebral artery occlusion in the rat.

Kleindienst A, Fazzina G, Dunbar JG, Glisson R, Marmarou A.

Acta Neurochir Suppl. 2006;96:303-6.

PMID:
16671476
43.

Effect of dimethyl sulfoxide on blood-brain barrier integrity following middle cerebral artery occlusion in the rat.

Kleindienst A, Dunbar JG, Glisson R, Okuno K, Marmarou A.

Acta Neurochir Suppl. 2006;96:258-62.

PMID:
16671466
44.

Bolus tracer delivery measured by MRI confirms edema without blood-brain barrier permeability in diffuse traumatic brain injury.

Beaumont A, Fatouros P, Gennarelli T, Corwin F, Marmarou A.

Acta Neurochir Suppl. 2006;96:171-4.

PMID:
16671449
45.

Traumatic brain edema in diffuse and focal injury: cellular or vasogenic?

Marmarou A, Signoretti S, Aygok G, Fatouros P, Portella G.

Acta Neurochir Suppl. 2006;96:24-9.

PMID:
16671417
46.

Mortality from traumatic brain injury.

Lu J, Marmarou A, Choi S, Maas A, Murray G, Steyerberg EW; Impact and Abic Study Group.

Acta Neurochir Suppl. 2005;95:281-5.

PMID:
16463866
47.

Contribution of raised ICP and hypotension to CPP reduction in severe brain injury: correlation to outcome.

Marmarou A, Saad A, Aygok G, Rigsbee M.

Acta Neurochir Suppl. 2005;95:277-80.

PMID:
16463865
48.

Three-year outcome of shunted idiopathic NPH patients.

Aygok G, Marmarou A, Young HF.

Acta Neurochir Suppl. 2005;95:241-5.

PMID:
16463857
49.

Guidelines for management of idiopathic normal pressure hydrocephalus: progress to date.

Marmarou A, Black P, Bergsneider M, Klinge P, Relkin N; International NPH Consultant Group.

Acta Neurochir Suppl. 2005;95:237-40.

PMID:
16463856
50.

Mitochondrial injury measured by proton magnetic resonance spectroscopy in severe head trauma patients.

Marmarou A, Signoretti S, Fatouros P, Aygok GA, Bullock R.

Acta Neurochir Suppl. 2005;95:149-51.

PMID:
16463840

Supplemental Content

Loading ...
Support Center